Hematopoietic growth factor after autologous peripheral blood transplantation: Comparison of G-CSF and GM-CSF

Bone Marrow Transplantation

Volumn 23, Issue 12, 1999, Pages 1251-1256

  Jansen, J ^a,b   Thompson, E M ^a   Hanks, S ^a   Greenspan, A R ^a   Thompson, J M ^a   Dugan, M J ^a   Akard, L P ^a  

^a Indiana Blood and Marrow Transplantation   (United States)

^b IBMT   (United States)

Author keywords

Engraftment; G CSF; GM CSF; Stem cell transplant; Supportive care

Indexed keywords

ANTIBIOTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MYELOMA; NEUTROPHIL; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE TRANSFUSION;

EID: 0033516304     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701806     Document Type: Article

References (27)

1. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical use of blood stem cells. Blood 1997; 89: 2333-2258.
2. Gillespie TW, Hillyer CD. Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies. Transfusion 1996; 36: 611-624.
3. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation in Europe 1996. Bone Marrow Transplant 1998; 22: 227-240.
4. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery-phase peripheral blood stem cell transplants, bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
5. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
6. Peters WP, Rosner G, Ross M et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood 1993; 81: 1709-1719.
7. Sheridan WP, Begley CG, Juttner CA et al Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 349: 640-644.
8. Spitzer G, Adkins DR, Spencer V et al. Randomized study of growth factors post-peripheral blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 1994; 12: 661-670.
9. Klumpp TR, Mangan KF, Goldberg SL et al. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol 1995; 13: 1323-1327.
10. Tarella C, Castellino C, Locatelli F et al. G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplant 1998; 21: 401-407.
11. McQuaker IG, Hunter AE, Pacey S et al. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997; 15: 451-457.
12. Linch DC, Milligan DW, Winfield DA et al. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol 1997; 99: 933-938.
13. Legros M, Fleury J, Bay JO et al. rhGM-CSF vs placebo following rhGM-CSF mobilized PBPC transplantation: a phase III double-blind randomized trial. Bone Marrow Transplant 1997; 19: 209-213.
14. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
15. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
16. Akard LP, Wiemann M, Thompson JM et al. Impaired stem cell collection by consecutive courses of high dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF. J Hematother 1996; 5: 271-277.
17. Eder JP, Elias A, Shea TC et al. A phase I/II study of cyclophosphamide, thiotepa and carboplatin with autologous bone marrow transplantation in solid tumor patients. J Clin Oncol 1990; 8: 1239-1245.
18. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
19. Akard LP, Lane J, Wiemann M et al. Hematopoietic reconstitution following peripheral stem cell (PBSC) transplant. Blood 1993; 82: 428a.
20. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
21. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
22. + peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998; 4: 84-92.
23. Meisenberg B, Brehm T, Schmeckel A et al. A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells. Transfusion 1998; 38: 209-215.
24. Brandt SJ, Peters WP, Atwater SK et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New Engl J Med 1988; 318: 869-876.
25. Jagannath S, Vesole DH, Zhang M et al. Feasibility and cost-effectiveness of outpatient transplants in multiple myeloma. Bone Marrow Transplant 1997; 20: 445-450.
26. Bolwell BJ, Pohlman B, Andresen S et al. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial. Bone Marrow Transplant 1998; 21: 369-373.
27. Faucher C, Le Coroller AG, Chabannon C et al. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study. Bone Marrow Transplant 1996; 17: 533-536.